文献速递脑血管病

动脉病影响儿童缺血性卒中表现,但镰状细胞病影响卒中管理

Arteriopathy Influences Pediatric Ischemic Stroke Presentation, but Sickle Cell Disease Influences Stroke Management.
PubMed 文献 · Stroke · 2019-01-01

本研究基于国际儿童卒中研究(IPSS)930例急性动脉缺血性卒中患儿,比较伴与不伴镰状细胞病(SCD)者的临床表现和管理。动脉病(不论SCD状态)增加偏瘫和言语异常风险,但仅无SCD者头痛风险增加。SCD患儿较少接受超声心动图和抗血栓治疗,即使存在动脉病。

要点

  • 动脉病增加儿童卒中偏瘫(OR 1.94)和言语异常(OR 1.67)风险,与SCD状态无关。
  • SCD患儿较少接受超声心动图(OR 0.58)和抗血栓治疗(OR 0.14),即使存在动脉病。
  • 无SCD患儿中,动脉病与更高的抗血栓治疗可能性相关(OR 5.36)。

核心结论

  • 动脉病而非SCD状态对卒中表现影响最大,但SCD状态影响卒中管理。
  • SCD患儿较少接受超声心动图和抗血栓治疗,需进一步研究管理差异是否合理。

研究设计与样本

  • 基于国际儿童卒中研究(IPSS)的队列分析,纳入930例急性动脉缺血性卒中患儿。
  • 按SCD和动脉病状态分组比较临床表现与管理,采用回归模型分析相对贡献。

主要发现

  • 930例中98例伴SCD(67例有动脉病),466例无SCD(392例有动脉病)。
  • 动脉病增加偏瘫风险(OR 1.94;95%CI 1.46-2.56)和言语异常风险(OR 1.67;95%CI 1.29-2.19)。
  • 动脉病增加头痛风险仅见于无SCD者(OR 1.89;95%CI 1.40-2.55)。
  • SCD患儿超声心动图检查较少(OR 0.58;95%CI 0.37-0.93),但心脏异常检出频率两组相似(P=0.57)。
  • SCD患儿抗血栓治疗较少(OR 0.14;95%CI 0.08-0.22);无SCD者中动脉病与抗血栓治疗相关(OR 5.36;95%CI 3.55-8.09)。

临床怎么用

  • 对儿童动脉缺血性卒中应评估动脉病,因其影响临床表现。
  • SCD患儿卒中管理需关注超声心动图和抗血栓治疗的使用差异。

局限性

  • 原文未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background and Purpose- Sickle cell disease (SCD) and arteriopathy are pediatric stroke risk factors that are not mutually exclusive. The relative contributions of sickled red blood cells and arteriopathy to stroke risk are unknown, resulting in unclear guidelines for primary and secondary stroke prevention when both risk factors are present. We hypothesized that despite similarities in clinical presentation and radiographic appearance of arteriopathies, stroke evaluation and management differ in children with SCD compared with those without SCD. Methods- We compared presentation and management of children with and without SCD enrolled in the IPSS (International Pediatric Stroke Study) with acute arterial ischemic stroke, according to SCD and arteriopathy status. Regression modeling determined relative contribution of SCD and arteriopathy in variables with significant frequency differences. Results- Among 930 childhood arterial ischemic strokes, there were 98 children with SCD, 67 of whom had arteriopathy, and 466 without SCD, 392 of whom had arteriopathy. Arteriopathy, regardless of SCD status, increased likelihood of hemiparesis (odds ratio [OR], 1.94; 95% CI, 1.46-2.56) and speech abnormalities (OR, 1.67; 95% CI, 1.29-2.19). Arteriopathy also increased likelihood of headache but only among those without SCD (OR, 1.89; 95% CI, 1.40-2.55). Echocardiograms were less frequently obtained in children with SCD (OR, 0.58; 95% CI, 0.37-0.93), but the frequency of identified cardiac abnormalities was similar in both groups ( P=0.57). Children with SCD were less likely to receive antithrombotic therapy, even in the presence of arteriopathy (OR, 0.14; 95% CI, 0.08-0.22). Arteriopathy was associated with a significantly higher likelihood of antithrombotic therapy in children without SCD (OR, 5.36; 95% CI, 3.55-8.09). Conclusions- Arteriopathy, and not SCD status, was most influential of stroke presentation. However, SCD status influenced stroke management because children with SCD were less likely to have echocardiograms or receive antithrombotic therapy. Further work is needed to determine whether management differences are warranted.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Guilliams KP, Kirkham FJ, Holzhauer S, et al. Arteriopathy Influences Pediatric Ischemic Stroke Presentation, but Sickle Cell Disease Influences Stroke Management. Stroke. 2019. PMID: 31009343. doi:10.1161/STROKEAHA.118.022800

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。